Fast Natural Wart Removal

Description

The product is identified by SPL Code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the removal of common warts, characterized by a rough, cauliflower-like appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and soaking in warm water for approximately 5 minutes may facilitate this process. After cleansing, the area must be dried completely. A small amount of the medication should then be applied to cover each wart, ensuring that it is allowed to dry. This application should be repeated twice daily as necessary, with treatment continuing for a maximum duration of 12 weeks.

Contraindications

Use is contraindicated in the following situations:

Application on irritated or infected skin, or areas exhibiting redness is prohibited due to the potential for exacerbating the condition.

Patients with diabetes or poor blood circulation should not use this product, as it may pose an increased risk of complications.

Additionally, the product should not be applied to birthmarks, warts with hair growth, or moles, as these conditions may lead to adverse reactions.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes. In the event of accidental exposure to the eyes, the affected area should be rinsed thoroughly with water for at least 15 minutes. Additionally, inhalation of vapors should be avoided to prevent respiratory irritation.

In cases of ingestion, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

This product should not be applied to irritated or infected skin, including areas that are reddened. Caution is advised for individuals with diabetes or poor blood circulation, as well as for use on birthmarks, warts with hair growth, or moles.

If discomfort persists following application, the use of this product should be discontinued immediately.

Side Effects

Patients using this product should be aware that it is intended for external use only. Care should be taken to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to rinse thoroughly with water for at least 15 minutes. Additionally, patients should avoid inhaling vapors associated with the product.

In the case of persistent discomfort, it is advised that patients discontinue use and consult a healthcare professional.

Drug Interactions

No specific drug interactions have been identified for the product. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Fast Natural Wart Removal (salicylic acid 17%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use has not been established, and the safety and effectiveness of this medication in children have not been determined. It is essential for healthcare professionals to consult with a qualified health professional before administering this medication to pediatric patients.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is essential to evaluate the potential risks and benefits in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Additionally, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring of vital signs and laboratory parameters may be necessary to assess the patient's condition and guide further treatment decisions.

In summary, while specific overdosage information is not available, healthcare professionals should remain vigilant and prepared to implement standard overdose management strategies to ensure patient safety and optimal outcomes.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional before use. No specific non-teratogenic effects have been identified. Additionally, there are no detailed findings related to nonclinical toxicology or animal pharmacology and toxicology available.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that if the medication is swallowed, it is crucial to seek immediate medical assistance or contact a Poison Control Center. This action is essential to ensure the safety and well-being of the patient.

Additionally, patients who are pregnant or breastfeeding should be encouraged to consult with a healthcare professional prior to using the medication. This consultation is important to assess any potential risks and to ensure appropriate care for both the patient and the child.

Storage and Handling

The product is supplied in a tube format, with specific handling and storage requirements to ensure its integrity and effectiveness. It should be stored at room temperature, away from direct light exposure. To maintain the quality of the product, it is essential to keep the tube tightly closed when not in use. Additionally, the product should be discarded after opening to prevent any potential degradation or contamination.

Additional Clinical Information

The product is administered topically, with a recommended application of a small amount to cover each wart, allowing it to dry. This process should be repeated twice daily as needed, for a maximum duration of 12 weeks.

Clinicians should counsel patients on the following precautions: the product is for external use only and should not come into contact with the eyes; if exposure occurs, the eyes should be rinsed with water for 15 minutes. Patients are advised to avoid inhaling vapors and to refrain from using the product on irritated or infected skin, reddened areas, birthmarks, warts with hair growth, or moles. Additionally, individuals who are diabetic or have poor blood circulation should exercise caution. Pregnant or breastfeeding patients should consult a healthcare professional prior to use. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Fast Natural Wart Removal, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)